column
CRISPR/Cas9 in red blood cell-related diseases: breakthroughs in gene editing and therapy
Yu Jin, Yu Zhang, Yating Ling, Qiang Fu, Chengtao He
2026, 10(1): 1-8. DOI: 10.46701/BG.20260101002
Abstract FullText HTML PDF
Advancing the treatment of myelodysplastic syndrome: a focus on immunotherapy and nanotherapy
Yaoyao Wang, Ting Yang
2026, 10(1): 9-29. DOI: 10.46701/BG.20260101185
Abstract FullText HTML PDF
Clinical value of predicting lower extremity deep vein thrombosis based on nomogram combined with four-item thrombosis assay in transfused ICU patients
Xuehua He, Jiajia Qiao, Xiuzhe Wang, Xiaojing Yang, Xiaojun Guo, Yuesheng Wu, Qiang Zhang
2026, 10(1): 30-36. DOI: 10.46701/BG.20260101773
Abstract FullText HTML PDF
Risk analysis of hemolysis and establishment of prenatal prediction model in newborns due to maternal-fetal ABO blood type incompatibility
Hua Lu, Yi Zhu, Qi Gao, Luochuan Zhang, Chao Wan, Xiaomin Xu, Yijun Hou, Jun Yang, Feng Liu
2026, 10(1): 37-42. DOI: 10.46701/BG.20260101297
Abstract FullText HTML PDF
Enhancing blood transfusion safety through extended Rh matching in preparation for electronic crossmatch in Hezhou
Shanchang Chen, Yanxia Mo, Renming Huang, Yu Zhong, Jikai Zhou, Yuxiang Huang, Miaoli Hu, Xiang Lu, Yan Tan, Pingping Guo, Yan Liu, Fangfang Chen, Hongjun Gao
2026, 10(1): 43-49. DOI: 10.46701/BG.20260101581
Abstract FullText HTML PDF